| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 10/28/2004 | WO2004092179A1 Spiro derivative, production process, and antioxidant |
| 10/28/2004 | WO2004092176A1 Pyrrolo[1,2-b]pyridazine compounds and their uses |
| 10/28/2004 | WO2004092173A2 A2a adenosine receptor antagonists |
| 10/28/2004 | WO2004092172A2 Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosin e receptor antagonists |
| 10/28/2004 | WO2004092171A2 Triazolo[1,5-a]pyrimidines and pyrazolo[1,5-a]pyrimidines useful as a2a adenosin e receptor antagonists |
| 10/28/2004 | WO2004092170A2 Triazolotriazines and pyrazolotriazines useful as a2a adenosine receptor antagon ists |
| 10/28/2004 | WO2004092169A1 Spiropiperidine compound and medicinal use thereof |
| 10/28/2004 | WO2004092168A1 Cgrp receptor antagonists |
| 10/28/2004 | WO2004092166A2 Cgrp receptor antagonists |
| 10/28/2004 | WO2004092163A1 Phenylazole compound, production process, and antioxidant drug |
| 10/28/2004 | WO2004092155A1 Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof |
| 10/28/2004 | WO2004092153A1 Diamine derivative, production process, and antioxidizing drug |
| 10/28/2004 | WO2004092136A1 Nitrogenous heterocyclic compound and use thereof |
| 10/28/2004 | WO2004092128A1 Anhydrous crystalline forms of (2s, 4s)-1-{(2r)-2-amino-3-‘4-methoxybenzyl)sulfonyl!-3-methylbutanoyl}-4-fluoropyrrolindine-2-carbonitrile |
| 10/28/2004 | WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 10/28/2004 | WO2004091723A1 Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles |
| 10/28/2004 | WO2004091663A1 Drug for nerve regeneration |
| 10/28/2004 | WO2004091651A1 Prongf as a pharmaceutically active agent for treating demyelinating diseases |
| 10/28/2004 | WO2004091646A2 Use of slurp-1 for treating diseases related to acetylcholine receptors dysfunction |
| 10/28/2004 | WO2004091636A1 Phosphate derivatives of pharmaceutical products |
| 10/28/2004 | WO2004091633A1 Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.o]non-1 (7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof |
| 10/28/2004 | WO2004091630A1 Remedies for diseases to be applied to eye |
| 10/28/2004 | WO2004091628A1 Receptor antagonist |
| 10/28/2004 | WO2004091624A1 Combinations comprising paroxetine and 2- (s) - (4-fluoro-2-methyl-phenyl) -piperazine-1-carboxylic acid [1- (r)- (3,5-bis-trifluoro-2-methyl-phenyl) -ethyl]-methyl amide for treatment of depression and/or anxiety |
| 10/28/2004 | WO2004091617A1 Combination of paroxetine and 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)- (2s-phenyl-piperidin-3s-yl)-amine for treatment of depression and/or anxiety |
| 10/28/2004 | WO2004091616A1 Combinations of paroxetine and 4- (s) - (4-acetyl-piperazin-1-yl) -2- (r)- (4-fluoro-2-methyl-phenyl -piperidine-1-carboxylic acid [1- (r) -(3,5-bis-trifluoromethyl-phenyl) -ethyl] methylamide for treatment of depression and / or anxiety |
| 10/28/2004 | WO2004091615A1 Combinations of paroxetine and 2-(r)-(4-fluoro-2-methyl-phenyl)-4-(s)-((8as)-6-oxo-hexahydro-pyrrolo[1,2-a]-pyrazin-2-yl)-piperidine-1-carboxylic acid[1-(r)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methylamide for treatment of depression/anxiety |
| 10/28/2004 | WO2004091609A2 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit |
| 10/28/2004 | WO2004091593A2 Methods for the treatment of pain comprising opioid antagonists |
| 10/28/2004 | WO2004091475A2 Gaucher disease drugs and methods of identifying same |
| 10/28/2004 | WO2004083375A3 Methods of promoting the differentiation of stem cells |
| 10/28/2004 | WO2004082581A3 Use of derivatives of cholest-4-en-3-one as medicaments, pharmaceutical compositions containing same, novel derivatives and preparation method thereof |
| 10/28/2004 | WO2004075823A8 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 10/28/2004 | WO2004072643A3 Diagnostics and therapeutics for diseases associated with glucagon-like peptide 2 receptor (glp2r) |
| 10/28/2004 | WO2004056827A3 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 10/28/2004 | WO2004047925A3 Therapeutic oxidation catalysts |
| 10/28/2004 | WO2004004648A3 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 10/28/2004 | WO2003095613A3 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 10/28/2004 | WO2003089573A3 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 10/28/2004 | WO2003077840A3 Method of modulating inflammatory response |
| 10/28/2004 | WO2001081540A3 Growth factor which acts through erb b-4 rtk |
| 10/28/2004 | WO2001039723A3 Triazospiro compounds having nociceptin receptor affinity |
| 10/28/2004 | US20040215025 formation of by-products by polymerisation of the alkylating agent is avoided whereby a reduction in the amount of alkylating reagent to be used is made possible; high yields |
| 10/28/2004 | US20040215023 Crystal and process for producing the same |
| 10/28/2004 | US20040215019 Substituted isoindoles and the e use thereof |
| 10/28/2004 | US20040215014 Auroyl cyclic amines for controlling behavior or appetite |
| 10/28/2004 | US20040214899 aqueous solutions of citric acid, disodium phosphate and (S)-4-{{3-[2-(dimethylaminoethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone, used for prophylaxis of headaches; drug delivery devices; nasal sprays |
| 10/28/2004 | US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal |
| 10/28/2004 | US20040214888 Carboxylic acid derivative and medicine comprising salt or ester of the same |
| 10/28/2004 | US20040214886 for the treatment and/or prophylaxis of diseases, in particular, states of pain and neurodegenerative disorders |
| 10/28/2004 | US20040214875 Imidazolinylmethyl aralkylsulfonamides |
| 10/28/2004 | US20040214864 Novel compounds |
| 10/28/2004 | US20040214859 Zolpidem hemitartrate |
| 10/28/2004 | US20040214858 For use in short-term therapy of insomnia |
| 10/28/2004 | US20040214853 Analgesics; side effect reduction; antidiabetic agents; central nervous system disorders |
| 10/28/2004 | US20040214849 via injection or intravenous drip |
| 10/28/2004 | US20040214846 A heteroaryl carbamic acid, secondary amide or amine, or phthalimidoyl derivatives; prevent from getting the disease or condition; cognitive impairment, Down's syndrome, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type, cerebral amyloid angiopathy, neurodegenerative disease |
| 10/28/2004 | US20040214843 Such as spiro(cyclohexane-1-4'-(3',4'-dihydro)quinazolin)-2'(1'H)-one for treatment of T-cell-related diseases, autoimmune diseases, osteoarthritis, multiple sclerosis, osteoporosis, asthma and cancer |
| 10/28/2004 | US20040214842 comprises opioid analgesic agent (morphine, codeine, fentanyl, and/or methadone) and compound that binds to SS1 or SS2 subunit of sodium channel, such as tetrodotoxin and saxitoxin; side effect reduction |
| 10/28/2004 | US20040214839 administering prostaglandin or agonist thereof and type IV selective phosphodiesterase (PDE) inhibitor to induce tolerance to antigens |
| 10/28/2004 | US20040214830 2,7-Substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives as ligands for serotonin receptors |
| 10/28/2004 | US20040214822 Substituted 4-aminocyclohexanol compounds |
| 10/28/2004 | US20040214815 Therapeutic compounds |
| 10/28/2004 | US20040214814 Pyrazole compounds useful as protein kinase inhibitors |
| 10/28/2004 | US20040214776 (truncated GDNF) proteins that promote dopamine uptake by dopaminergic cells and promote the survival of nerve cells |
| 10/28/2004 | US20040214775 Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein |
| 10/28/2004 | US20040214762 administering serine protease inhibitors and optionally in combination with substance P or peptide hormones, for prophylaxis of nervous system disorders, autoimmune disorders and tissue regeneration processes, such as wound healing |
| 10/28/2004 | US20040214759 Compositions and methods of use for a fibroblast growth factor |
| 10/28/2004 | US20040214746 Pharmaceutical composition of a tachykinin receptor antagonist |
| 10/28/2004 | US20040214332 Stable, multipotent transgenic nervous system progenitor tissue for treatment and prevention of neurodegenerative disorders |
| 10/28/2004 | US20040214234 Method |
| 10/28/2004 | US20040214195 Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy |
| 10/28/2004 | US20040213855 Pharmaceutical composition for the treatment of acute disorders |
| 10/28/2004 | US20040213832 non-rate controlled, monolithic, subsaturated patch for transdermal delivery of fentanyl and analogs thereof at a rate and in an amount sufficient to induce and maintain analgesia over a period of at least three days, and up to 7 days to a patient in need thereof |
| 10/28/2004 | US20040213816 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 10/28/2004 | US20040213800 Active immunization to generate antibodies to soluble A-beta |
| 10/28/2004 | US20040213797 Conjugates for the modulation of immune responses |
| 10/28/2004 | CA2527175A1 Remedies for diseases to be applied to eye |
| 10/28/2004 | CA2522712A1 Nerve regenerating drug |
| 10/28/2004 | CA2522471A1 Methods for the treatment of pain comprising opioid antagonists |
| 10/28/2004 | CA2522313A1 Combinations comprising paroxetine and 2-(s)-(4-fluoro-2-methyl-phenyl)-piperazine-1-carboxylic acid [1-(r)-(3,5-bis-trifluoro-2-methyl-phenyl)-ethyl]-methyl amide for treatment of depression and/or anxiety |
| 10/28/2004 | CA2522311A1 Combinations of paroxetine and 4-(s)-(4-acetyl-piperazin-1-yl)-2-(r)-(4-fluoro-2-methyl-phenyl-piperidine-1-carboxylic acid [1-(r)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]methylamide for treatment of depression and / or anxiety |
| 10/28/2004 | CA2522266A1 Phenylazole compound, production process therefor and antioxidant |
| 10/28/2004 | CA2522076A1 Method for identifying modulators of g protein coupled receptor signaling |
| 10/28/2004 | CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 10/28/2004 | CA2521842A1 Phosphate derivatives of pharmaceutical products |
| 10/28/2004 | CA2521839A1 Augmented cognitive training |
| 10/28/2004 | CA2521836A1 Phosphates of secondary alcohols |
| 10/28/2004 | CA2521808A1 Computer-based model for identification and characterization of non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
| 10/28/2004 | CA2521394A1 Pharmaceutical compositions for intranasal administration of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.o]non-1 (7)-en-2-yl)alkyl] phosphonic acid and derivatives and methods of use thereof |
| 10/28/2004 | CA2520805A1 Pyrrolo[1,2-b]pyridazine compounds and their uses |
| 10/28/2004 | CA2520029A1 Slurp-1 compositions and methods of use thereof |
| 10/28/2004 | CA2517155A1 Fluoro-and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof |
| 10/27/2004 | EP1471064A1 Coumarin derivatives, process for their production and use thereof |
| 10/27/2004 | EP1471055A1 6-phenylpyridyl-2-amine derivatives |
| 10/27/2004 | EP1471054A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 10/27/2004 | EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 10/27/2004 | EP1470818A1 Use of piperazine phenothiazine derivatives in the manufacture of a medicament with neuroprotector and/or neurotrophic effects on cns and/or pns |
| 10/27/2004 | EP1470815A1 Opiod formulations for treating pain |
| 10/27/2004 | EP1470257A2 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |